K Number
K973652
Device Name
DUOCLIPPER TITANIUM CLIPS
Date Cleared
1998-03-27

(183 days)

Product Code
Regulation Number
878.4300
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The indications for the use of the DuoClip Titanium Clips are the same as those for a Hemostatic Clips (Product Code 79MCH, Class1, Regulation# 878.4300). The indications is for ligating blood vessels.
Device Description
Not Found
More Information

Not Found

No
The summary describes a simple mechanical device (hemostatic clips) and contains no mention of AI, ML, image processing, or any other technology typically associated with AI/ML in medical devices.

No
The device, DuoClip Titanium Clips, is indicated for "ligating blood vessels," which is a treatment for a medical condition. Therefore, it is a therapeutic device.

No
The device is indicated for ligating blood vessels, which is a therapeutic or surgical function, not a diagnostic one.

No

The device is described as "DuoClip Titanium Clips" and is indicated for "ligating blood vessels," which strongly suggests a physical, hardware-based device (clips) rather than software. The predicate device is also "Hemostatic Clips," further supporting this conclusion.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is for "ligating blood vessels." This is a surgical procedure performed in vivo (within the living body) to stop bleeding.
  • IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body (like blood, urine, or tissue) to detect diseases, conditions, or infections. They are performed in vitro (outside the living body).
  • Lack of IVD Characteristics: The description does not mention any analysis of biological samples, diagnostic testing, or any of the typical characteristics of an IVD.
  • Predicate Device: The predicate device is a "Hemostatic Clip," which is also a surgical device used for in vivo procedures.

Therefore, the DuoClip Titanium Clips are surgical devices used for hemostasis in vivo, not IVDs.

N/A

Intended Use / Indications for Use

The indications for the use of the DuoClip Titanium Clips are the same as those for a Hemostatic Clips (Product Code 79MCH, Class1, Regulation# 878.4300).

The indications is for ligating blood vessels.

Product codes

FZP

Device Description

Not Found

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K973652

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 878.4300 Implantable clip.

(a)
Identification. An implantable clip is a clip-like device intended to connect internal tissues to aid healing. It is not absorbable.(b)
Classification. Class II.

0

Image /page/0/Picture/1 description: The image is a logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three tail feathers, representing the three branches of government. The eagle is enclosed in a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

MAR 27 1998

Mr. Stephen Chakoff President SCION International, Incorporated 5200 Blue Lagoon Drive, Suite 890 Miami, Florida 33126

Re: K973652 Trade Name: DuoClipper Titanium Clips Regulatory Class: II Product Code: FZP Dated: December 29, 1997 December 31, 1997 Received:

Dear Mr. Chakoff:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, qood manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Requlation (QS) for Medical General regulation (21 CFR Part 820) and that, Devices: through periodic (QS) inspections, the Food and Druq Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory In addition, FDA may publish further announcements action. concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

1

Page 2 - Mr. Chakoff

This letter will allow you to begin marketing your device as described in your 510 (k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

Celia M. Witten, Ph.D.

Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

2

Image /page/2/Picture/0 description: The image shows a series of bold, black numbers and letters. The sequence appears to be 'K93652'. Below the numbers, there is some smaller text that is difficult to read, but it seems to say 'Page 1 of 1'. The image is high contrast, with the black text standing out against a white background.

510(k) Number (if known):

DuoClip Titanium Clips Device Name: _________________________________________________________________________________________________________________________________________________________________

Indications For Use:

The indications for the use of the DuoClip Titanium Clips are the same as those for a Hemostatic Clips (Product Code 79MCH, Class1, Regulation# 878.4300).

The indications is for ligating blood vessels.

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off)
Division of General Restorative Devices
510(k) NumberK973652
Prescription Use
(Per 21 CFR 801.109)X OR Over-The-Counter Use
(Optional Format 1-2-96)